Dr Reddy’s acquires six OTC brands in US

27 May 2016 - Deborah Wilkes

Archived

Indian generics company Dr Reddy’s said it had entered the branded consumer healthcare arena in the US by acquiring six OTC brands – including the Bufferin and Doan's pain relievers – from Ducere Pharma for an undisclosed sum.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: